Malignancies in Prader-Willi Syndrome: Results From a Large International Cohort and Literature Review
The Journal of Clinical Endocrinology & Metabolism · 2023
DOI: 10.1210/clinem/dgad312 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2023. Verfasst von Karlijn Pellikaan und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Division of Endocrinology, Erasmus Medical Center, University Medical Centre Rotterdam, 3015 GD Rotterdam, The Nethe…. Hauptthemen laut MEDLINE: Adenocarcinoma, Prader-Willi Syndrome. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Context
Prader-Willi syndrome (PWS) is a complex disorder combining hypothalamic dysfunction, neurodevelopmental delay, hypotonia, and hyperphagia with risk of obesity and its complications. PWS is caused by the loss of expression of the PWS critical region, a cluster of paternally expressed genes on chromosome 15q11.2-q13. As life expectancy of patients with PWS increases, age-related diseases like malignancies might pose a new threat to health.
Objective
To investigate the prevalence and risk factors of malignancies in patients with PWS and to provide clinical recommendations for cancer screening.
Methods
We included 706 patients with PWS (160 children, 546 adults). We retrospectively collected data from medical records on past or current malignancies, the type of malignancy, and risk factors for malignancy. Additionally, we searched the literature for information about the relationship between genes on chromosome 15q11.2-q13 and malignancies.
Results
Seven adults (age range, 18-55 years) had been diagnosed with a malignancy (acute lymphoblastic leukemia, intracranial hemangiopericytoma, melanoma, stomach adenocarcinoma, biliary cancer, parotid adenocarcinoma, and colon cancer). All patients with a malignancy had a paternal 15q11-13 deletion. The literature review showed that several genes on chromosome 15q11.2-q13 are related to malignancies.
Conclusion
Malignancies are rare in patients with PWS. Therefore, screening for malignancies is only indicated when clinically relevant symptoms are present, such as unexplained weight loss, loss of appetite, symptoms suggestive of paraneoplastic syndrome, or localizing symptoms. Given the increased cancer risk associated with obesity, which is common in PWS, participation in national screening programs should be encouraged.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Division of Endocrinology, Erasmus Medical Center, University Medical Centre Rotterdam, 3015 GD Rotterdam, The Netherlands.
- Center for Adults with Rare Genetic Syndromes, Department of Internal Medicine, Division of Endocrinology, Erasmus Medical Center, University Medical Center Rotterdam, 3015 GD Rotterdam, The Netherlands.
- Dutch Center of Reference for Prader-Willi Syndrome, 3015 GD Rotterdam, The Netherlands.
- Academic Center for Growth Disorders, Erasmus Medical Center, University Medical Centre Rotterdam, 3015 GD Rotterdam, The Netherlands.
- Assistance Publique-Hôpitaux de Paris, Rare Diseases Center of Reference 'Prader-Willi Syndrome and Obesity with Eating Disorders' (PRADORT), Nutrition Department, Institute of Cardiometabolism and Nutrition, ICAN, Piti…
- International Network for Research, Management & Education on adults with Prader-Willi Syndrome (INfoRMEd-PWS).
ORCID-Profile: Karlijn Pellikaan, Anthony P Goldstone, Christine Poitou, Aart J van der Lely, Laura C G de Graaff
Zitieren
APA
Pellikaan, K., Nguyen, N. Q. C., Rosenberg, A. G. W., Coupaye, M., Goldstone, A. P., Høybye, C., Markovic, T., Grugni, G., Crinò, A., Caixàs, A., Poitou, C., Corripio, R., Nieuwenhuize, R. M., van der Lely, A. J., & de Graaff, L. C. G. (2023). Malignancies in Prader-Willi Syndrome: Results From a Large International Cohort and Literature Review. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgad312
Vancouver
Pellikaan K, Nguyen NQC, Rosenberg AGW, Coupaye M, Goldstone AP, Høybye C, et al. Malignancies in Prader-Willi Syndrome: Results From a Large International Cohort and Literature Review. The Journal of Clinical Endocrinology & Metabolism. 2023. doi:10.1210/clinem/dgad312
BibTeX
@article{Pellikaan2023,
author = {Pellikaan, Karlijn and Nguyen, Naomi Q C and Rosenberg, Anna G W and Coupaye, Muriel and Goldstone, Anthony P and Høybye, Charlotte and Markovic, Tania and Grugni, Graziano and Crinò, Antonino and Caixàs, Assumpta and Poitou, Christine and Corripio, Raquel and Nieuwenhuize, Rosa M and van der Lely, Aart J and de Graaff, Laura C G},
title = {Malignancies in Prader-Willi Syndrome: Results From a Large International Cohort and Literature Review},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2023},
doi = {10.1210/clinem/dgad312}
}
EUVIMED